3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
7
Lymphoma, Non-Hodgkin
5
Recurrence
2
Lymphoma
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Advanced Liver Cancers
1
Interventions
Fluorouracil
11
Oxaliplatin
9
Leucovorin
7
Capecitabine
7
pembrolizumab
6
Specimen Handling
6
Nivolumab
6
trastuzumab deruxtecan
5
Magnetic Resonance Spectroscopy
5
fludarabine
4
Trastuzumab
4
Paclitaxel
4
Docetaxel
4
Cyclophosphamide
4
Cisplatin
4
Biopsy
4
zimberelimab
3
aldesleukin
3
Ramucirumab
3
ulixertinib
2
fludarabine phosphate
2
Irinotecan
2
Folfox protocol
2
zolbetuximab
1
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
toripalimab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
tocilizumab
×
30 days
×
Clear all
No trials found.